Literature DB >> 2445489

Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene.

V L Bautch1, S Toda, J A Hassell, D Hanahan.   

Abstract

Inoculation of newborn mice with the murine polyoma (Py) virus leads to tumor formation in a wide range of tissues. In order to investigate viral oncogenesis, we generated transgenic mice carrying either the Py large T antigen (LT) gene or the Py middle T antigen (MT) gene linked to Py early region regulatory sequences. While Py LT mice exhibit no phenotype, Py MT mice develop multifocal tumors of the vascular endothelium. These hemangiomas are lethal to the animals and can be passaged in vivo. Transgene RNAs and protein are present in both hemangiomas and the testes of these mice, and the Py middle T protein in both tissues is complexed to a cellular tyrosine kinase. The expression of complexed middle T protein in both tumorigenic endothelial cells and unperturbed testes implies that endothelial cells may be particularly susceptible to the action of the middle T oncogene. These observations indicate that Py middle T disrupts the normal strict controls on vascular growth, and suggest that Py MT transgenic mice will provide a model for studying the control of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445489     DOI: 10.1016/0092-8674(87)90122-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  41 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progression.

Authors:  Steven Kao; Jeffrey Mo; Andrew Baird; Brian P Eliceiri
Journal:  Oncol Rep       Date:  2012-03-07       Impact factor: 3.906

3.  Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

Authors:  A Larose; N Dyson; M Sullivan; E Harlow; M Bastin
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 4.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

5.  The amino terminus of polyomavirus middle T antigen is required for transformation.

Authors:  D N Cook; J A Hassell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.

Authors:  S P Yee; D Mock; P Greer; V Maltby; J Rossant; A Bernstein; T Pawson
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

7.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines.

Authors:  L Juillerat-Jeanneret; A Aguzzi; O D Wiestler; P Darekar; R C Janzer
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

8.  Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.

Authors:  Sulochana S Bhandarkar; Marisa Jaconi; Levi E Fried; Michael Y Bonner; Benjamin Lefkove; Baskaran Govindarajan; Betsy N Perry; Ravi Parhar; Jamie Mackelfresh; Allie Sohn; Michael Stouffs; Ulla Knaus; George Yancopoulos; Yvonne Reiss; Andrew V Benest; Hellmut G Augustin; Jack L Arbiser
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

9.  Mice with hemangiomas induced by transgenic endothelial cells. A model for the Kasabach-Merritt syndrome.

Authors:  N Dubois-Stringfellow; L Kolpack-Martindale; V L Bautch; R G Azizkhan
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

10.  Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors.

Authors:  C Garlanda; C Parravicini; M Sironi; M De Rossi; R Wainstok de Calmanovici; F Carozzi; F Bussolino; F Colotta; A Mantovani; A Vecchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.